Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of BK1304 in Healthy Children
jRCT2031200156Phase 2Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of BK1304 in influenza, sponsored by Research Foundation for Microbial Diseases of Osaka University. Primary endpoints: Response rate of nasal IgA antibody, Geometric mean titer of nasal IgA antibody and 8 more. Started Oct 2020; status: completed.
02
Drugs
BK1304
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2031200156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200156.